These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22298629)

  • 1. Anti-conflict effect of 5-HT1A agonists in rats: a new model for evaluating anxiolytic-like activity.
    Hascoët M; Bourin M; Todd KG; Coüetoux du Tertre A
    J Psychopharmacol; 1994 Jan; 8(4):227-37. PubMed ID: 22298629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonin receptors on punished behavior of rats.
    Witkin JM; Perez LA
    Behav Pharmacol; 1989; 1(3):247-254. PubMed ID: 11224036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT1A agonists 8-OH-DPAT, buspirone and ipsapirone attenuate stress-induced anorexia in rats.
    Dourish CT; Kennett GA; Curzon G
    J Psychopharmacol; 1987 Jan; 1(1):23-30. PubMed ID: 22158750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
    Barrett JE; Witkin JM; Mansbach RS; Skolnick P; Weissman BA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats.
    Klint T
    Behav Pharmacol; 1991 Dec; 2(6):481-489. PubMed ID: 11224090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminated taste aversion with a 5-HT(1A) agonist measured using saccharin preference.
    Lucki I; Marcoccia JM
    Behav Pharmacol; 1991 Nov; 2(4 And 5):335-344. PubMed ID: 11224077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test.
    Schreiber R; De Vry J
    Behav Pharmacol; 1993 Dec; 4(6):625-636. PubMed ID: 11224231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding.
    Mansbach RS; Harrod C; Hoffmann SM; Nader MA; Lei Z; Witkin JM; Barrett JE
    J Pharmacol Exp Ther; 1988 Jul; 246(1):114-20. PubMed ID: 2455786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased rates of punished responding produced by buspirone-like compounds in rats.
    Sanger DJ
    J Pharmacol Exp Ther; 1992 May; 261(2):513-7. PubMed ID: 1349641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonflict effects of the 5-HT1A compound flesinoxan.
    Barrett JE; Gleeson S; Nader MA; Hoffmann SM
    J Psychopharmacol; 1989 Jan; 3(2):64-9. PubMed ID: 22156500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
    Abe M; Tabata R; Saito K; Matsuda T; Baba A; Egawa M
    J Pharmacol Exp Ther; 1996 Aug; 278(2):898-905. PubMed ID: 8768745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
    Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.